Table 2.
Concentrations of lipid peroxidation biomarkers in urine samples.
| Biomarkers | Case (n = 70) | Control (n = 29) |
|---|---|---|
| Median (IQR) (ng mg−1 creatinine) | Median (IQR) (ng mg−1 creatinine) | |
| 15(R)-15-F2t-IsoP | 0.72 (0.5, 1.56) | 0.7 (0.48, 0.94) |
| PGE2 | 1.98 (0.62, 3.5) | 1.69 (0.93, 4.26) |
| 15-keto-15-E2t-IsoP | 0.93 (0.53, 1.47) | 1.02 (0.65, 1.54) |
| 15-keto-15-F2t-IsoP | 0.84 (0.22, 1.94) | 1.33 (0.58, 2) |
| 2,3-dinor-15-epi-15-F2t-IsoP | 0.78 (0.53, 1.22) | 0.65 (0.47, 1.09) |
| 15-E2t-IsoP | 0.23 (0.06, 1.31) | 0.16 (0.07, 0.58) |
| 5-F2t-IsoP | 2.67 (1.68, 5.07) | 2.37 (1.76, 3.37) |
| 15-F2t-IsoP | 0.01 (0, 0.02) | 0.01 (0, 0.02) |
| PGF2α | 3.72 (2.79, 7.32) | 3.38 (2.35, 5.17) |
| 4(RS)-4-F4t-NeuroP | 0.89 (0.67, 1.36) | 0.72 (0.5, 1.01) |
| 1a,1b-dihomo-PGF2α | 1.33 (0.64, 2.48) | 1.67 (1.05, 2.23) |
| 10-epi-10-F4t-NeuroP | 0.03 (0, 0.06) | 0.01 (0, 0.05) |
| 14(RS)-14-F4t-NeuroP | 1.21 (0.76, 2.16) | 1.27 (0.74, 1.94) |
| ent-7(RS)-7-F2t-dihomo-IsoP | 0.33 (0.14, 0.63) | 0.28 (0.19, 0.36) |
| 17-F2t-dihomo-IsoP | 0.09 (0, 0.38) | 0.11 (0, 0.26) |
| 17-epi-17-F2t-dihomo-IsoP | 0.01 (0, 0.07) | 0 (0, 0) |
| 17(RS)-10-epi-SC-Δ15-11-dihomo-IsoF | 0.03 (0, 0.1) | 0.05 (0.03, 0.08) |
| 7(RS)-ST-Δ8-11-dihomo-IsoF | 0 (0, 0.02) | 0 (0, 0.03) |
IQR, inter-quartile range; IsoP, isoprostane; dihomo-IsoP, dihomo-isoprostane; dihomo-IsoF, dihomo-isofuran, NeuroP, neuroprostane;